المؤلفون: Montes, AF, Lopez, CL, Martinez, GA, Lopez, DP, Munoz, AML, Paredes, BG, Abad, DG, Lopez, CC, Fonseca, PJ, Plazas, JG, Doldan, MCL, de Castro, EM, Canovas, MS, Puyal, MT, Ayala, BL, Martel, IJ, Flores, ML, Carmona-Bayonas, A

المصدر: ONCOLOGIST
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname

مصطلحات موضوعية: Survival, Antiangiogenic, Aflibercept, Prognosis, Colorectal cancer, Real-world data, Nomogram

URL الوصول: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::f0078608c3c4b9e12d13289b6915f17e
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=2861

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Bockorny B; Beth Israel Deaconess Medical Center, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Macarulla T; Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Semenisty V; Rambam Health Care Campus, Haifa, Israel., Borazanci E; HonorHealth/TGen, Scottsdale, Arizona., Feliu J; Hospital Universitario La Paz. IdIPAZ. Cátedra UAM-AMGEN, CIBERONC, Madrid, Spain., Ponz-Sarvise M; Clinica Universidad de Navarra and Program in Solid Tumors (CIMA), Universidad de Navarra, IDISNA, Pamplona, Spain., Abad DG; Grupo Oncologia Fuenlabrada, Madrid, Spain., Oberstein P; New York University Langone Health, New York, New York., Alistar A; Atlantic Health System, Morristown, New Jersey., Muñoz A; Hospital General Universitario Gregorio Marañón, Universidad Complutense, Madrid, Spain., Geva R; Tel Aviv Sourasky Medical Center, Tel Aviv, Israel., Guillén-Ponce C; Servicio de Oncología Médica. Hospital Universitario Ramón y Cajal. IRYCIS. Madrid, Spain., Fernandez MS; Complejo Hospitalario Universitario de Ourense, Ourense, Spain., Peled A; Biokine Therapeutics Ltd., Ness Ziona, Israel.; Goldyne Savad Institute of Gene Therapy, Hebrew University Hospital, Jerusalem, Israel., Chaney M; Early Development Oncology, Merck & Co., Inc., Kenilworth, New Jersey., Gliko-Kabir I; BioLineRx, Modi'in, Israel., Shemesh-Darvish L; BioLineRx, Modi'in, Israel., Ickowicz D; BioLineRx, Modi'in, Israel., Sorani E; BioLineRx, Modi'in, Israel., Kadosh S; StatExcellence Ltd., Nesher, Israel., Vainstein-Haras A; BioLineRx, Modi'in, Israel., Hidalgo M; Weill Cornell Medical College, New York, New York. mah4006@med.cornell.edu.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2021 Sep 15; Vol. 27 (18), pp. 5020-5027. Date of Electronic Publication: 2021 Jul 12.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal, Humanized/*administration & dosage , Antineoplastic Combined Chemotherapy Protocols/*administration & dosage , Carcinoma, Pancreatic Ductal/*drug therapy , Fluorouracil/*administration & dosage , Irinotecan/*administration & dosage , Leucovorin/*administration & dosage , Pancreatic Neoplasms/*drug therapy , Peptides/*administration & dosage, Adult ; Aged ; Aged, 80 and over ; Carcinoma, Pancreatic Ductal/secondary ; Female ; Humans ; Liposomes ; Male ; Middle Aged ; Nanoparticles ; Pancreatic Neoplasms/pathology

المؤلفون: Bockorny B; Division of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Semenisty V; Oncology, Rambam Health Care Campus, Haifa, Israel., Macarulla T; Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, IOB Quirón, Barcelona, Spain., Borazanci E; HonorHealth Research Institute, Scottsdale, AZ, USA.; Translational Genomics Research Institute, Phoenix, AZ, USA., Wolpin BM; Harvard Medical School, Boston, MA, USA.; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA., Stemmer SM; Institute of Oncology, Davidoff Center, Rabin Medical Center, Petah Tikva, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Golan T; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; Oncology, Chaim Sheba Medical Center, Tel-Hashomer, Israel., Geva R; Oncology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.; Tel-Aviv University, Tel Aviv, Israel., Borad MJ; Oncology, Mayo Clinic Cancer Center, Scottsdale, AZ, USA., Pedersen KS; Oncology, Washington University School of Medicine, St. Louis, MO, USA., Park JO; Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea., Ramirez RA; Oncology, Ochsner Medical Center, New Orleans, LA, USA., Abad DG; Grupo Oncologia Fuenlabrada, Madrid, Spain., Feliu J; Instituto de Investigación Hospital Universitario La Paz (IdIPAZ), Cátedra UAM-AMGEN, CIBERONC, Madrid, Spain., Muñoz A; Medical Oncology Service, Instituto de Investigación Sanitaria Hospital Gregorio Marañón, Universidad Complutense, Madrid, Spain., Ponz-Sarvise M; Clinica Universidad de Navarra and Program in Solid Tumors (CIMA), Universidad de Navarra, IDISNA, Pamplona, Spain., Peled A; Goldyne Savad Institute of Gene Therapy, Hebrew University of Jerusalem, Jerusalem, Israel., Lustig TM; BioLineRx Ltd, Modi'in, Israel., Bohana-Kashtan O; BioLineRx Ltd, Modi'in, Israel., Shaw SM; BioLineRx Ltd, Modi'in, Israel., Sorani E; BioLineRx Ltd, Modi'in, Israel., Chaney M; Early Oncology Development, Merck & Co., Inc, Kenilworth, NJ, USA., Kadosh S; StatExcellence Ltd, Nesher, Israel., Vainstein Haras A; BioLineRx Ltd, Modi'in, Israel., Von Hoff DD; HonorHealth Research Institute, Scottsdale, AZ, USA.; Translational Genomics Research Institute, Phoenix, AZ, USA., Hidalgo M; Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, New York, NY, USA. mah4006@med.cornell.edu.; New York Presbyterian Hospital, New York, NY, USA. mah4006@med.cornell.edu.

المصدر: Nature medicine [Nat Med] 2020 Jun; Vol. 26 (6), pp. 878-885. Date of Electronic Publication: 2020 May 25.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Carcinoma, Pancreatic Ductal/*drug therapy , Liver Neoplasms/*drug therapy , Lung Neoplasms/*drug therapy , Pancreatic Neoplasms/*drug therapy , Peritoneal Neoplasms/*drug therapy , Retroperitoneal Neoplasms/*drug therapy, Aged ; Aged, 80 and over ; Antibodies, Monoclonal, Humanized/administration & dosage ; Antineoplastic Agents, Immunological ; CD8-Positive T-Lymphocytes/pathology ; Carcinoma, Pancreatic Ductal/pathology ; Carcinoma, Pancreatic Ductal/secondary ; Female ; Fluorouracil/administration & dosage ; Humans ; Irinotecan/administration & dosage ; Leucovorin/administration & dosage ; Liver Neoplasms/secondary ; Lung Neoplasms/secondary ; Lymph Nodes/pathology ; Lymphatic Metastasis ; Lymphocytes, Tumor-Infiltrating/pathology ; Male ; Middle Aged ; Myeloid-Derived Suppressor Cells/pathology ; Pancreatic Neoplasms/pathology ; Peptides/administration & dosage ; Peritoneal Neoplasms/secondary ; Receptors, CXCR4/antagonists & inhibitors ; Retroperitoneal Neoplasms/secondary ; Survival Rate ; T-Lymphocytes, Regulatory/pathology ; Treatment Outcome

المؤلفون: Thomas JL; Division of Cardiology, Good Samaritan Hospital, Los Angeles, California, USA., Al-Ameri H, Economides C, Shareghi S, Abad DG, Mayeda G, Burstein S, Shavelle DM

المصدر: The Journal of invasive cardiology [J Invasive Cardiol] 2010 Aug; Vol. 22 (8), pp. 360-4.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: HMP Communications Country of Publication: United States NLM ID: 8917477 Publication Model: Print Cited Medium: Internet ISSN: 1557-2501 (Electronic) Linking ISSN: 10423931 NLM ISO Abbreviation: J Invasive Cardiol Subsets: MEDLINE

مواضيع طبية MeSH: Heart-Assist Devices* , Severity of Illness Index*, Heart Diseases/*surgery , Shock, Cardiogenic/*surgery, Aged ; Aged, 80 and over ; Aortic Valve Stenosis/epidemiology ; Aortic Valve Stenosis/surgery ; Cardiomyopathies/epidemiology ; Cardiomyopathies/surgery ; Female ; Follow-Up Studies ; Heart Diseases/epidemiology ; Humans ; Male ; Middle Aged ; Myocardial Infarction/epidemiology ; Myocardial Infarction/surgery ; Myocarditis/epidemiology ; Myocarditis/surgery ; Retrospective Studies ; Risk Factors ; Shock, Cardiogenic/epidemiology ; Treatment Outcome